Phio Pharmaceuticals (PHIO) Gains from Investment Securities (2016 - 2021)
Historic Gains from Investment Securities for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to $1000.0.
- Phio Pharmaceuticals' Gains from Investment Securities changed N/A to $1000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $5000.0 for FY2024, which is 8076.92% down from last year.
- Per Phio Pharmaceuticals' latest filing, its Gains from Investment Securities stood at $1000.0 for Q4 2021.
- Phio Pharmaceuticals' Gains from Investment Securities' 5-year high stood at $620000.0 during Q1 2019, with a 5-year trough of $1000.0 in Q4 2021.
- For the 5-year period, Phio Pharmaceuticals' Gains from Investment Securities averaged around $118088.6, with its median value being $53180.0 (2018).
- In the last 5 years, Phio Pharmaceuticals' Gains from Investment Securities skyrocketed by 19663.65% in 2018 and then plummeted by 9967.74% in 2020.
- Phio Pharmaceuticals' Gains from Investment Securities (Quarter) stood at $50180.0 in 2017, then skyrocketed by 213.9% to $157514.0 in 2018, then surged by 293.62% to $620000.0 in 2019, then crashed by 99.68% to $2000.0 in 2020, then tumbled by 50.0% to $1000.0 in 2021.
- Its Gains from Investment Securities was $1000.0 in Q4 2021, compared to $2000.0 in Q1 2020 and $620000.0 in Q1 2019.